Jiangxi Shantai Health Industry Development Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Jiangxi Shantai Health Industry Development Co., Ltd. - overview
Established
2018
Location
Nanchang, -, China
Primary Industry
Biotechnology
About
Based in China, and founded in 2018, Jiangxi Shantai Health Industry Development Co. , Ltd. develops microecological and immune-related medical technologies. The company was founded by Wang Jingsu.
In August 2022, Jiangxi Shantai Health Industry Development Co. , Ltd. raised series A funding from Huihong Capital. The company’s product line includes HPV virus removal products, probiotic products, and intestinal flora products.
It provides patients with better treatment by developing medicinal technologies related to immunity and microecology, such as centenarian probiotics, tumor immunotherapy, anti-aging management, and immune function management. The company plans to use the funds raised in August 2022 for clinical research of enterobacterial transplantation in tumors, autism, and infection diseases; microecological drug pipeline development; team and market channel construction; and building an industrial innovation service platform with immune microecological technology as the core.
Current Investors
Huihong Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.shanxingshengwu.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.